GSK drops drug prices for poor nations
The world's second-biggest drug company is cutting its prices for some countries – but not for HIV patients, writes Qudsiya Karrim.
comments (0)
GlaxoSmithKline urged to pool its patents on HIV drugs
Leading UK and international organisations have written to Britain's largest drug company urging it to pool its patents on HIV medicines.
comments (0)
Protesters seek cheaper drugs at HIV/Aids meeting
Protesters disrupted a large HIV/Aids conference in Indonesia on Wednesday to demand access to drugs to treat HIV patients dying from hepatitis C.
comments (0)
Cash crisis hits Aids fund
The Global Fund to Fight Aids, Malaria and TB, the largest funder of Aids programmes worldwide, has an estimated shortfall of $3-billion to $5-billion
comments (0)
